Zwijnaarde, Belgium
October 5, 2010

today announced that an additional 7,866 common shares have been issued by the Company as the result of the exercise of warrants. As a result of this transaction, Devgen now has 19,676,642 shares outstanding.

Regulated information

In accordance with Article 15 §1 of the Act of May 2, 2007 on the disclosure of major shareholdings,  Devgen nv

Information as of October 5, 2010:

Basic data

Total share capital (EUR)	1,475,745.82
Total number of securities conferring voting rights	19,676,642
Total number of voting rights (the denominator):	19,676,642
Total number of securities conferring voting rights by category:	N/A
Total number of voting rights by category	N/A

Additional facts

Total number of convertible bonds conferring voting rights	none
Total number of rights, materialized by certificates or not, to subscribe  to not yet issued securities which confer voting rights	1,531,957
Total number of voting rights which result from the exercise of these conversion or subscription rights	1,531,957
Total number of shares without voting rights	none

Devgen's mission is to enable farmers to sustainably grow more food on less land, with less water, agrochemicals and labour.

Devgen uses advanced biotechnology and molecular breeding technology to make high yielding seeds and crop protection solutions with a superior environmental profile. Devgen brings this technology to the market in the world's major food and feed crops through two complementary strategies:

-   licensing Devgen technology for use in corn, cotton and soy and selected other crops in exchange for R&D funding, and milestone and royalty payments;

-   producing and selling its premium hybrid seeds in major field crops such as rice, sunflower, sorghum, and pearl millet, in the Indian subcontinent and South-East Asia.

In its Crop Protection unit, Devgen developed an agro-chemical product that protects crops from damage by parasitic nematodes. This nematicide was launched in Turkey and in US.

Incorporated in 1997, Devgen has offices in Ghent (Belgium), and has subsidiaries in Singapore, Hyderabad (India), General Santos (Philippines) and Delaware (US), totaling about 280 employees.